NeuroSense Therapeutics Ltd. Key Management Personnel Compensation Share-based Payment
NeuroSense Therapeutics Ltd. (NRSN) reported Key Management Personnel Compensation Share-based Payment of $2.50 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes › Compensation Related Costs
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment · last filed 2024-04-04
| Period end | Key Management Personnel Compensation Share-based Payment 12 month |
|---|---|
| 2023-12-31 | $2.50M 20-F · filed 2024-04-04 |
| 2022-12-31 | $4.57M 20-F · filed 2024-04-04 |
| 2021-12-31 | $1.71M 20-F · filed 2024-04-04 |
| 2020-12-31 | $66.00K 20-F · filed 2023-03-22 |
| 2019-12-31 | $230.00K 20-F · filed 2022-04-14 |